{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 477248526
| IUPAC_name = (17&beta;)-17-(prop-2-en-1-yl)estr-4-en-17-ol
| image = Allylestrenol.svg
| width = 200

<!--Clinical data-->
| tradename =  Gestanin, Gestanol, Gestanon, Gestin, Gestormone, Gestrenol, Maintaine Tab., Orageston, Premaston, Profar, Turinal<ref name="IndexNominum2000" /><ref name="Elks2014" /><ref name="Martindale" />
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B / C / D / X -->
| pregnancy_category = Used in threatened miscarriage and recurrent pregnancy loss
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C -->
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status =  
| routes_of_administration =

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =
<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 432-60-0
| ATC_prefix = G03
| ATC_suffix = DC01
| PubChem = 235905
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB01431
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 205855
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = I47VB5DZ8O
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D01374
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 1445549
| synonyms = Allyloestrenol; Allyl estrenol; Allyl oestrenol; 17α-Allylestr-4-en-17β-ol; SC-6393<ref name="Elks2014" />

<!--Chemical data-->
| C=21 | H=32 | O=1
| molecular_weight = 300.48 g/mol
| smiles = O[C@]2(CC[C@H]1[C@H]4[C@H](CC[C@@]12C)[C@@H]3\C(=C/CCC3)CC4)C\C=C
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C21H32O/c1-3-12-21(22)14-11-19-18-9-8-15-6-4-5-7-16(15)17(18)10-13-20(19,21)2/h3,6,16-19,22H,1,4-5,7-14H2,2H3/t16-,17+,18+,19-,20-,21-/m0/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = ATXHVCQZZJYMCF-XUDSTZEESA-N
}}

'''Allylestrenol''' ([[International Nonproprietary Name|INN]]) (brand names '''Gestanon''', '''Gestanin''', '''Orageston''', '''Turinal''', '''Gestin''', others), or '''allyloestrenol''' ([[British Approved Name|BAN]]), also known as '''17α-allylestr-4-en-17β-ol''' or as '''3-deketo-17α-allyl-19-nortestosterone''',<ref name="Publishing2013">{{cite book|author=William Andrew Publishing|title=Pharmaceutical Manufacturing Encyclopedia, 3rd Edition|url=https://books.google.com/books?id=_J2ti4EkYpkC&pg=PA170|date=22 October 2013|publisher=Elsevier|isbn=978-0-8155-1856-3|pages=170–}}</ref> is a [[steroid]]al [[progestin]] of the [[19-nortestosterone]] and [[17α-allyltestosterone]] groups<ref name="Aronson2009">{{cite book|author =Jeffrey K. Aronson|title=Meyler's Side Effects of Endocrine and Metabolic Drugs|url=https://books.google.com/books?id=BWMeSwVwfTkC&pg=PA289|date=21 February 2009|publisher=Elsevier|isbn=978-0-08-093292-7|pages=289–}}</ref><ref name="BerginkLoonen1985">{{cite journal|last1=Bergink|first1=E.W.|last2=Loonen|first2=P.B.A.|last3=Kloosterboer|first3=H.J.|title=Receptor binding of allylestrenol, a progestagen of the 19-nortestosterone series without androgenic properties|journal=Journal of Steroid Biochemistry|volume=23|issue=2|year=1985|pages=165–168|issn=0022-4731|doi=10.1016/0022-4731(85)90232-8|pmid=3928974}}</ref><ref name="Zeelen1990">{{cite book|author=F. J. Zeelen|title=Medicinal chemistry of steroids|url=https://books.google.com/books?id=px9tAAAAMAAJ|year=1990|publisher=Elsevier Science Limited|isbn=978-0-444-88727-6|pages=108–109|quote=Other examples are allylestrenol (42), a pro-drug converted to the 3-keto analogue (43), which is used in the treatment of threatened abortion [78,79] and altrenogest (44), used in sows and mares to suppress ovulation and estrus behaviour [80]. [...] Progestins with a 17a-allyl side chain: (42) allylestrenol, (43), (44) altrenogest.}}</ref> that is used to prevent [[miscarriage|threatened miscarriage]], [[habitual abortion|recurrent pregnancy loss]] and [[premature labor]].<ref name="IndexNominum2000">{{cite book|title=Index Nominum 2000: International Drug Directory|url=https://books.google.com/books?id=5GpcTQD_L2oC&pg=PA29|date=January 2000|publisher=Taylor & Francis|isbn=978-3-88763-075-1|pages=29–}}</ref><ref name="Elks2014">{{cite book|author=J. Elks|title=The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies|url=https://books.google.com/books?id=0vXTBwAAQBAJ&pg=PA31|date=14 November 2014|publisher=Springer|isbn=978-1-4757-2085-3|pages=31–}}</ref><ref name="Martindale">{{cite book |editor=Sweetman, Sean C. |chapter=Sex hormones and their modulators |title=Martindale: the complete drug reference |edition=36th |year=2009 |page=2082 |publisher=Pharmaceutical Press |location=London|isbn=978-0-85369-840-1}}</ref><ref>{{cite journal |vauthors=Cortés-Prieto J, Bosch AO, Rocha JA |title=Allylestrenol: three years of experience with Gestanon in threatened abortion and premature labor |journal=Clinical Therapeutics |volume=3 |issue=3 |pages=200–8 |year=1980 |pmid=7459930}}</ref> It has also been studied as a treatment for [[benign prostatic hyperplasia]] in men, with encouraging results.<ref>{{cite journal |vauthors=Fukuoka H, Ishibashi Y, Shiba T, Tuchiya F, Sakanishi S |title=[Clinical study of allylestrenol (Perselin) on patients with prostatic hypertrophy] |language=Japanese |journal=Hinyokika Kiyo. Acta Urologica Japonica |volume=39 |issue=7 |pages=679–83 |date=July 1993 |pmid=7689782}}</ref><ref>{{cite journal |vauthors=Noguchi K, Takeda M, Hosaka M, Kubota Y |title=[Clinical effects of allylestrenol on patients with benign prostatic hyperplasia (BPH) evaluated with criteria for treatment efficacy in BPH] |language=Japanese |journal=Hinyokika Kiyo. Acta Urologica Japonica |volume=48 |issue=5 |pages=269–73 |date=May 2002 |pmid=12094708}}</ref> Allylestrenol is marketed widely throughout [[Europe]], including in the [[United Kingdom]] (no longer available), [[Russia]], and many other European countries, and is also available in [[Japan]], [[Hong Kong]], [[India]], [[Bangladesh]], [[Indonesia]], and much of [[Southeast Asia]], though notably not in the [[United States]] or [[Canada]].<ref name="IndexNominum2000" /><ref name="Martindale" /><ref name="WiltMacDONALD2002">{{cite journal|last1=Wilt|first1=Timothy J.|last2=MacDONALD|first2=RODERICK|last3=Nelson|first3=David|title=TAMSULOSIN FOR TREATING LOWER URINARY TRACT SYMPTOMS COMPATIBLE WITH BENIGN PROSTATIC OBSTRUCTION: A SYSTEMATIC REVIEW OF EFFICACY AND ADVERSE EFFECTS|journal=The Journal of Urology|volume=167|issue=1|year=2002|pages=177–183|issn=0022-5347|doi=10.1016/S0022-5347(05)65407-9|quote=The 2 studies more than 13 weeks in duration compared tamsulosin with drugs not used in the United States for BPH, namely allyestrenol 24 and chlormadinone.}}</ref><ref name="Drugs.com">https://www.drugs.com/international/allylestrenol.html</ref>

Although it is less potent as a progestogen relative to many other 19-nortestosterone derivatives,<ref name="pmid13699366">{{cite journal | vauthors = FIELD-RICHARDS S, SNAITH L | title = Allylestrenol: a new oral progestogen | journal = Lancet | volume = 1 | issue = 7169 | pages = 134–6 | year = 1961 | pmid = 13699366 | doi = 10.1016/s0140-6736(61)91310-1| url = }}</ref> allylestrenol is said to be virtually devoid of [[androgen]]ic, [[estrogen]]ic, or [[glucocorticoid]] activity, and hence, unlike virtually all other 19-nortestosterone derivatives, appears to be a pure [[progestogen]] with similar effects to those of [[progesterone]].<ref name="BerginkLoonen1985" /><ref name="Madjerekde Visser1960">{{cite journal|last1=Madjerek|first1=Z.|last2=de Visser|first2=J.|last3=van der Vies|first3=J.|last4=Overbeek|first4=G. A.|title=ALLYLESTRENOL, A PREGNANCY MAINTAINING ORAL GESTAGEN|journal=European Journal of Endocrinology|volume=XXXV|issue=I|year=1960|pages=8–19|issn=0804-4643|doi=10.1530/acta.0.XXXV0008}}</ref> As it is lacking in a [[keto group]] at the C3 position, allylestrenol is thought to be a [[prodrug]] into [[17α-allyl-19-nortestosterone]] (or 17α-allylnandrolone).<ref name="pmid18395441">{{cite journal | vauthors = McRobb L, Handelsman DJ, Kazlauskas R, Wilkinson S, McLeod MD, Heather AK | title = Structure-activity relationships of synthetic progestins in a yeast-based in vitro androgen bioassay | journal = J. Steroid Biochem. Mol. Biol. | volume = 110 | issue = 1-2 | pages = 39–47 | year = 2008 | pmid = 18395441 | doi = 10.1016/j.jsbmb.2007.10.008 | url = }}</ref><ref name="Zeelen1990" /> It was patented in 1958<ref name="Publishing2013" /> and has been marketed since 1961.<ref name="Field-RichardsSnaith1961">{{cite journal|last1=Field-Richards|first1=Sara|last2=Snaith|first2=Linton|title=ALLYLESTRENOL : A NEW ORAL PROGESTOGEN|journal=The Lancet|volume=277|issue=7169|year=1961|pages=134–136|issn=0140-6736|doi=10.1016/S0140-6736(61)91310-1|pmid=13699366}}</ref><ref name="SimpsonWeiner1997">{{cite book|author1=J. A. Simpson|author2=E. S. C. Weiner|title=Oxford English Dictionary Additions Series|url=https://books.google.com/books?id=gUGcAQAAQBAJ&pg=PA36|year=1997|publisher=Clarendon Press|isbn=978-0-19-860027-5|pages=36–|quote=1961 Lancet 21 Jan. 135/1 Allylestrenol ('Gestanin', Organon)..seems to be completely free from androgenic activity. 1962 Med. Jrnl. Austral. 8 Sept. 375/2 Each tablet of the combined hormone preparation, 'Premenquil', contains 5 mg. of allyloestrenol. [...]}}</ref><ref name="Juta1962">{{cite book|title=Medical Proceedings: A South African Journal for the Advancement of Medical Science|url=https://books.google.com/books?id=QORDAQAAIAAJ|year=1962|publisher=Juta and Company|quote=Just released in South Africa is Gestanin, Organon Laboratories' new safe oral progestogen. Gestanin is allylestrenol, one of a new group of steroids synthesized by Organon.}}</ref>

==See also==
* [[Altrenogest]]
* [[Ethylestrenol]]
* [[Lynestrenol]]

==References==
{{reflist|30em}}

==External links==
* [http://www.urotoday.com/38/browse_categories/prostate_cancer/aua_2007__prostate_cancer_basic_research_ii.html "AUA 2007 – Prostate Cancer Basic Research (II)" – Uro Today]

{{Progestogens and antiprogestogens}}
{{Progesterone receptor modulators}}

[[Category:Estranes]]
[[Category:Prodrugs]]
[[Category:Progestogens]]
[[Category:Allyl compounds]]